Authors were able to detect the expression of PD-1 and CD137 (Tumor Infiltrating Lymphocytes: TILs) and PD-L1 (tumor cells and antigen presenting cells) even when differences in tumor sizes were not significantly different upon the use of combination therapy vs. mono-therapy (56). This evidence concerns the gene PDCD1 and neoplasm.